Anticoagulation and restenosis after percutaneous transluminal coronary angioplasty
- 31 July 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (3) , 17-19
- https://doi.org/10.1016/0002-9149(87)90478-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Low-Molecular-Weight HeparinNew England Journal of Medicine, 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Influence of intimal dissection on restenosis after successful coronary angioplasty.Circulation, 1985
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983
- Morphology after Transluminal Angioplasty in Human BeingsNew England Journal of Medicine, 1981
- Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model.Circulation, 1980
- Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS).Circulation, 1979
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976